Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy.

Haptoglobin 2-2 phenotype is associated with decreased serum iron levels in endstage renal disease patients resistant to rhEPO therapy. Br J Biomed Sci. 2014;71(2):79-81 Authors: Martins F, Catarino C, Rocha-Pereira P, Reis F, Sameiro-Faria M, Miranda V, Belo L, Bronze-da-Rocha E, Costa E, Santos-Silva A PMID: 24974683 [PubMed - indexed for MEDLINE]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research